Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 4
2007 1
2008 1
2009 1
2010 2
2011 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
High-intensity focused ultrasound for prostate cancer: a systematic review.
Lukka H, Waldron T, Chin J, Mayhew L, Warde P, Winquist E, Rodrigues G, Shayegan B; Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Lukka H, et al. Clin Oncol (R Coll Radiol). 2011 Mar;23(2):117-27. doi: 10.1016/j.clon.2010.09.002. Epub 2010 Oct 6. Clin Oncol (R Coll Radiol). 2011. PMID: 20932728 Review.
Seven systematic reviews and two practice guidelines were identified; neither contained randomised controlled trials. ...Until results from case series are confirmed in prospective studies, the widespread use of HIFU is not supported....
Seven systematic reviews and two practice guidelines were identified; neither contained randomised controlled trials. ...Until result …
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.
Goffin J, Lacchetti C, Ellis PM, Ung YC, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Goffin J, et al. J Thorac Oncol. 2010 Feb;5(2):260-74. doi: 10.1097/JTO.0b013e3181c6f035. J Thorac Oncol. 2010. PMID: 20101151 Free article. Review.
Randomized studies suggest that platinum-based doublets (platinum plus new agent) are the standard of care for first-line systemic therapy. No one new agent is clearly superior for use in combination with a platinum agent. ...In patients at least 70 years of age or with Ea …
Randomized studies suggest that platinum-based doublets (platinum plus new agent) are the standard of care for first-line systemic th …
Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review.
Hamm C, Verma S, Petrella T, Bak K, Charette M; Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Hamm C, et al. Cancer Treat Rev. 2008 Apr;34(2):145-56. doi: 10.1016/j.ctrv.2007.10.003. Epub 2008 Feb 20. Cancer Treat Rev. 2008. PMID: 18077098 Review.
METHODS: A systematic review of the literature was conducted to locate randomized controlled trials, meta-analyses, systematic reviews, and evidence-based practice guidelines published up to April 2007. RESULTS: Nine eligible randomized controlled trials were identified, i …
METHODS: A systematic review of the literature was conducted to locate randomized controlled trials, meta-analyses, systematic reviews, and …
The management of thymoma: a systematic review and practice guideline.
Falkson CB, Bezjak A, Darling G, Gregg R, Malthaner R, Maziak DE, Yu E, Smith CA, McNair S, Ung YC, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Falkson CB, et al. J Thorac Oncol. 2009 Jul;4(7):911-9. doi: 10.1097/jto.0b013e3181a4b8e0. J Thorac Oncol. 2009. PMID: 19557895 Free article. Review.
Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline.
Cheng S, Evans WK, Stys-Norman D, Shepherd FA; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Cheng S, et al. J Thorac Oncol. 2007 Apr;2(4):348-54. doi: 10.1097/01.JTO.0000263720.15062.51. J Thorac Oncol. 2007. PMID: 17409809 Free article. Review.
External feedback was obtained from practitioners in Ontario, and the guideline was approved by the provincial lung cancer disease site group. RESULTS: Six randomized trials met the eligibility criteria and were included for review. One randomized phase III trial of oral t …
External feedback was obtained from practitioners in Ontario, and the guideline was approved by the provincial lung cancer disease site g …
Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.
Tsao MN, Lloyd NS, Wong RK, Rakovitch E, Chow E, Laperriere N; Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care. Tsao MN, et al. Cancer Treat Rev. 2005 Jun;31(4):256-73. doi: 10.1016/j.ctrv.2005.04.007. Cancer Treat Rev. 2005. PMID: 15951117 Review.
One older randomized trial examined the use of WBRT versus supportive care alone (using oral prednisone). Results were not conclusive. ...For patients with poor performance status and active extracranial disease, steroids and supportive care are an opt …
One older randomized trial examined the use of WBRT versus supportive care alone (using oral prednisone). Results were not con …
The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
Ellis P, Davies AM, Evans WK, Haynes AE, Lloyd NS; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Ellis P, et al. J Thorac Oncol. 2006 Jul;1(6):591-601. J Thorac Oncol. 2006. PMID: 17409924 Free article. Review.
External feedback was obtained from Ontario clinicians, and the guideline was approved by the provincial Lung Cancer Disease Site Group. RESULTS: One hundred nineteen studies were eligible, including eight randomized trials and 111 phase II trials. ...
External feedback was obtained from Ontario clinicians, and the guideline was approved by the provincial Lung Cancer Disease Site Group …
Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.
Okawara G, Ung YC, Markman BR, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Okawara G, et al. Lung Cancer. 2004 Apr;44(1):1-11. doi: 10.1016/j.lungcan.2003.09.020. Lung Cancer. 2004. PMID: 15013578 Review.
The Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care conducted a systematic review of literature published between 1985 and July 2003 and developed an evidence-based clinical practice guideline on postoperative radiothera …
The Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care conducted a systematic revie …
Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
Chu Q, Vincent M, Logan D, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Chu Q, et al. Lung Cancer. 2005 Dec;50(3):355-74. doi: 10.1016/j.lungcan.2005.06.010. Epub 2005 Aug 31. Lung Cancer. 2005. PMID: 16139391 Review.
Two phase III trials detected a statistically significant survival advantage for a taxane (paclitaxel or docetaxel) with best supportive care versus best supportive care alone. Among the nine fully published phase III trials comparing platinum-based ch …
Two phase III trials detected a statistically significant survival advantage for a taxane (paclitaxel or docetaxel) with best supportive …
16 results